Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens
Value Health
.
2014 Nov;17(7):A532.
doi: 10.1016/j.jval.2014.08.1692.
Epub 2014 Oct 26.
Authors
J Parrondo
1
,
Rodríguez D Rincón
2
,
Gómez M Romero
3
,
Lamoglia R Sola
4
,
C Roldán
1
Affiliations
1
GSK Spain, Tres Cantos, Spain.
2
Hospital General Universitario Gregorio Marañón, Madrid, Spain.
3
Hospital Universitario de Valme. Universidad de Sevilla, Sevilla, Spain.
4
Hospital del Mar IMIM - Universitat Autonoma de Barcelona, Barcelona, Spain.
PMID:
27201691
DOI:
10.1016/j.jval.2014.08.1692
No abstract available